BACKGROUND: Although depression is a risk factor for adverse outcomes in chronic illness, little is known about the prevalence or risk factors for depressive symptoms in chronic obstructive pulmonary disease (COPD). OBJECTIVE: To determine the prevalence of depressive symptoms in COPD as compared to other chronic illnesses and to identify risk factors for depressive symptoms in COPD. DESIGN AND PATIENTS: Cross-sectional study of 18,588 persons (1,736 subjects with self-reported COPD), representing a sample of the US population aged > or =50 years who participated in the 2004 Health and Retirement Survey. MEASUREMENTS: Presence of COPD and other chronic conditions was defined by self-report. Presence of depressive symptoms was assessed using the CES-D8 scale. Participants with a score > or =3 on CES-D8 were classified as having clinically significant depressive symptoms. MAIN RESULTS: Of 1,736 participants with COPD, 40% had > or =3 depressive symptoms. Depressive symptoms were more common in COPD than in coronary heart disease, stroke, diabetes, arthritis, hypertension, and cancer. Risk factors for > or =3 depressive symptoms in COPD: younger age (OR 1.02/per year younger, 95% CI [1.02-1.03]), female gender (1.2 [1.1-1.3]), current smoking (1.5 [1.3-1.7]), marital status [divorced/separated (1.8 [1.6-2.1]), widowed (1.8 [1.6-2]), never married (1.4 [1.1-1.8]), < or =high school degree (1.6 [1.5-1.8]), dyspnea (2.3 [2.1-2.6]), difficulty walking (2.8 [2.5-3.2]), and co-morbid diabetes (1.2 [1.1-1.4]), arthritis (1.3 [1.2-1.5]) or cancer (1.2 [1.1-1.4]). CONCLUSIONS: Depressive symptoms are common in COPD and are more likely to occur in COPD than in other common chronic illnesses. The risk factors identified may be used for targeted depression screening in COPD patients.
BACKGROUND: Although depression is a risk factor for adverse outcomes in chronic illness, little is known about the prevalence or risk factors for depressive symptoms in chronic obstructive pulmonary disease (COPD). OBJECTIVE: To determine the prevalence of depressive symptoms in COPD as compared to other chronic illnesses and to identify risk factors for depressive symptoms in COPD. DESIGN AND PATIENTS: Cross-sectional study of 18,588 persons (1,736 subjects with self-reported COPD), representing a sample of the US population aged > or =50 years who participated in the 2004 Health and Retirement Survey. MEASUREMENTS: Presence of COPD and other chronic conditions was defined by self-report. Presence of depressive symptoms was assessed using the CES-D8 scale. Participants with a score > or =3 on CES-D8 were classified as having clinically significant depressive symptoms. MAIN RESULTS: Of 1,736 participants with COPD, 40% had > or =3 depressive symptoms. Depressive symptoms were more common in COPD than in coronary heart disease, stroke, diabetes, arthritis, hypertension, and cancer. Risk factors for > or =3 depressive symptoms in COPD: younger age (OR 1.02/per year younger, 95% CI [1.02-1.03]), female gender (1.2 [1.1-1.3]), current smoking (1.5 [1.3-1.7]), marital status [divorced/separated (1.8 [1.6-2.1]), widowed (1.8 [1.6-2]), never married (1.4 [1.1-1.8]), < or =high school degree (1.6 [1.5-1.8]), dyspnea (2.3 [2.1-2.6]), difficulty walking (2.8 [2.5-3.2]), and co-morbid diabetes (1.2 [1.1-1.4]), arthritis (1.3 [1.2-1.5]) or cancer (1.2 [1.1-1.4]). CONCLUSIONS:Depressive symptoms are common in COPD and are more likely to occur in COPD than in other common chronic illnesses. The risk factors identified may be used for targeted depression screening in COPDpatients.
Authors: Peter de Jonge; Johan Ormel; Rob H S van den Brink; Joost P van Melle; Titia A Spijkerman; Astrid Kuijper; Dirk J van Veldhuisen; Maarten P van den Berg; Adriaan Honig; Harry J G M Crijns; Aart H Schene Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: Katherine A Ornstein; Melissa D Aldridge; Melissa M Garrido; Rebecca Gorges; Diane E Meier; Amy S Kelley Journal: JAMA Intern Med Date: 2015-07 Impact factor: 21.873
Authors: James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer Journal: Psychosom Med Date: 2014-10 Impact factor: 4.312
Authors: HwaJung Choi; Andrew Steptoe; Michele Heisler; Philippa Clarke; Robert F Schoeni; Stephen Jivraj; Tsai-Chin Cho; Kenneth M Langa Journal: JAMA Intern Med Date: 2020-07-13 Impact factor: 21.873
Authors: Laura J Julian; Steven E Gregorich; Gillian Earnest; Mark D Eisner; Hubert Chen; Paul D Blanc; Ed H Yelin; Patricia P Katz Journal: COPD Date: 2009-12 Impact factor: 2.409